Myanmar vs Serbia: Cause of death, by non-communicable diseases, ages 60+, female
Myanmar
77.1%
in 2021
Serbia
77.1%
in 2021
Myanmar rank
77th
Serbia rank
76th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Myanmar
- Serbia
How they compare
Serbia currently reports 77.1% against 77.1% in Myanmar, a difference of 0.0%.
Across all 6 years both countries report, Serbia has been ahead every year.
Myanmar ranks 77th and Serbia ranks 76th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.9% | 97.0% | 19.1% | Serbia |
| 2010s | 86.8% | 96.8% | 10.0% | Serbia |
| 2020s | 82.1% | 83.3% | 1.2% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Myanmar or Serbia?
- Serbia, at 77.1% against 77.1% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Myanmar and Serbia?
- 0.0%, with Serbia ahead.
- How many years of comparable data are there for Myanmar and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Serbia rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Myanmar ranks 77th and Serbia ranks 76th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.